Resultados de la búsqueda 2021-2030 of 16167 for Female Reproductive System

  1. Oncología (médica) - Ensayos clínicos

    Cholangiocarcinoma (CCA) has key similarities with HCC, therefore, we hypothesize that Sulf1 and Sulf2 may also play roles in promotion of CCA progression.

  2. Oncología (médica) - Ensayos clínicos

    In the phase II part, to evaluate the preliminary antitumor activity of two different doses/regimens of [177Lu]Lu-NeoB in combination with capecitabine (dose ...

  3. Oncología (médica) - Ensayos clínicos

    Scottsdale/Phoenix, Ariz., Rochester, Minn. This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor ...

  4. Oncología (médica) - Ensayos clínicos

    Patients with recurrent, platinum-sensitive high-grade serous ovarian cancer (HGSOC) including fallopian tube and primary peritoneal cancer expressing high ...

  5. Oncología (médica) - Ensayos clínicos

    The performance characteristics of the ddPCR assay for the detection of ctDNA mutation in uveal melanoma patients will be assessed by comparing the mutation ...

  6. Oncología (médica) - Ensayos clínicos

    This is a Phase 2 global, multi-center, open-label study to assess the efficacy, safety and tolerability of AZD0486 monotherapy in adult participants with ...

  7. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaluate the integration of cancer pan-genetic testing into a cancer clinical practice and understand both its use and effect in ...

  8. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to examine the microbiome and immune function in patients with active lymphoma, and in patients with a history of lymphoma who are ...

  9. Oncología (médica) - Ensayos clínicos

    This study aims to identify candidate High Grade Serous Cancer (HGSC) early detection and chemotherapy treatment response biomarkers.

  10. Oncología (médica) - Ensayos clínicos

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...